Inactivation of surrogate coronaviruses on hard surfaces by health care germicides

American Journal of Infection Control

Volumn 39, Issue 5, 2011, Pages 401-407

  Hulkower, Rachel L ^a   Casanova, Lisa M ^b   Rutala, William A ^c   Weber, David J ^c   Sobsey, Mark D ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

Coronavirus; disinfection; environmental; SARS; severe acute respiratory syndrome; surfaces

Indexed keywords

2 HYDROXYBIPHENYL; ALCOHOL; HYPOCHLORITE SODIUM; PHTHALALDEHYDE; STAINLESS STEEL;

ARTICLE; CLINICAL EFFECTIVENESS; DISINFECTION; ENVIRONMENTAL SANITATION; HEALTH CARE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; SANITATION; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRUS CARRIER;

ANTI-INFECTIVE AGENTS, LOCAL; DISINFECTION; ETHANOL; GLUTARAL; INFECTION CONTROL; MURINE HEPATITIS VIRUS; O-PHTHALALDEHYDE; PHENOLS; SODIUM HYPOCHLORITE; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRUS INACTIVATION;

EID: 79957907756     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.08.011     Document Type: Article

References (31)

1. Saif L, Denison M, Guan Y. Microbiology, ecology and natural history of coronaviruses. In: Knobler AM, Lemon S, Mack A, Sivitz L, Oberholtzer K, editors. Learning from SARS: Preparing for the next disease outbreak. Washington, DC: Institute of Medicine of the National Academies; 2004.
2. Aitken C, Jeffries D. Nosocomial spread of viral disease. Clin Microbiol Rev 2001;14:528.
3. Sattar S. Microbicides and the environmental control of nosocomial viral infections. J Hosp Infect 2004;56:64-9.
4. Cozad A, Jones R. Disinfection and prevention of infectious disease. Am J Infect Control 2003;31:243-54.
5. Rutala W, Peacock J, Gergen M, Sobsey M, Weber D. Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother 2006;50:1419.
6. Lee N, Sung J. Nosocomial transmission of SARS. Curr Infect Dis Rep 2003;5:473-6. (Pubitemid 38899179)
7. Dowell S, Simmerman J, ErdmanD, JulianWu J, Chaovavanich A, Javadi M, et al. Severe acute respiratory syndrome coronavirus onhospital surfaces. Clin Infect Dis 2004;39:652-7. (Pubitemid 39180436)
8. Hota B, Weinstein R. Contamination, disinfection, and crosscolonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004;39:1182-9.
9. Rabenau H, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr H. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol 2005;194:1-6. (Pubitemid 40064624)
10. Yu I, Xie Z, Tsoi K, Chiu Y, Lok S, Tang X, et al. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clin Infect Dis 2007;44:1017-25.
11. Berger A, Drosten C, Doerr H, St€urmer M, Preiser W. Severe acute respiratory syndrome (SARS): paradigm of an emerging viral infection. J Clin Virol 2004;29:13-22. (Pubitemid 37524081)
12. Dettenkofer M, Spencer R. Importance of environmental decontamination: a critical view. J Hosp Infect 2007;65:55-7. (Pubitemid 46805840)
13. Ansari S, Springthorpe V, Sattar S, Rivard S, Rahman M. Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol 1991;29:2115.
14. Sattar S. Hierarchy of susceptibility of viruses to environmental surface disinfectants: a predictor of activity against new and emerging viral pathogens. J AOAC Int 2007;90:1655-8.
15. Sehulster L, Chinn R, Arduino M, Carpenter J, Donlan R, Ashford D, et al. Guidelines for environmental infection control in health-care facilities. MMWR Recomm Rep 2003;52(RR10):1-42.
16. Rabenau H, Kampf G, Cinatl J, Doerr H. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect 2005;61:107-11. (Pubitemid 41283335)
17. Rutala W, Barbee S, Aguiar N, Sobsey M, Weber D. Antimicrobial activity of home disinfectants and natural products against potential human pathogens. Infect Control Hosp Epidemiol 2000;21:33-8.
18. Wang X, Li J, Jin M, Zhen B, Kong Q, Song N, et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods 2005;126:171-7. (Pubitemid 40558758)
19. Sattar S, Springthorpe V, Adegbunrin O, Zafer A, Busa M. A disc-based quantitative carrier test method to assess the virucidal activity of chemical germicides. J Virol Methods 2003;112:3-12. (Pubitemid 37338253)
20. Jackwood M. The relationship of severe acute respiratory syndrome coronavirus-with avian andother coronaviruses.AvianDiseases 2006;50:315-20.
21. Li P, Goldman N. Phylogenomics and bioinformatics of SARS-CoV. Trends Microbiol 2004;12:106-11. (Pubitemid 38314751)
22. Gorbalenya A, Snijder E, SpaanW. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol 2004;78:7863.
23. USEPA. OPP microbiology laboratory standard operating procedure for disinfectant sample preparation. Cincinnati (OH): USEPA; 2008.
24. Abad F, Pintó R, Bosch A. Disinfection of human enteric viruses on fomites. FEMS Microbiol Lett 1997;156:107-11. (Pubitemid 28091842)
25. Sizun J, Yu M, Talbot P. Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source of hospital-acquired infections. J Hosp Infect 2000;46:55-60.
26. Sattar S, Springthorpe V, Karim Y, Loro P. Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect 1989;102: 493-505. (Pubitemid 19166881)
27. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology 2007;212:119-23.
28. Rutala W. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996;24:313-42. (Pubitemid 26330733)
29. Hirano N, Fujiwara K, Hino S, Matumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Virol 1974;44:298-302.
30. McClurkinA, Norman J. Studies on transmissible gastroenteritis of swine: II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis. Can J Comp Med Vet Sci 1966;30:190.
31. Darnell M, Subbarao K, Feinstone S, Taylor D. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods 2004;121:85-91. (Pubitemid 39180029)